Form 8-K - Current report:
SEC Accession No. 0001641172-25-008841
Filing Date
2025-05-06
Accepted
2025-05-06 16:10:25
Documents
16
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41922
2 EX-99.1 ex99-1.htm EX-99.1 148639
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6021
  Complete submission text file 0001641172-25-008841.txt   434107

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lfmd-20250506.xsd EX-101.SCH 3819
5 XBRL DEFINITION FILE lfmd-20250506_def.xml EX-101.DEF 26700
6 XBRL LABEL FILE lfmd-20250506_lab.xml EX-101.LAB 36865
7 XBRL PRESENTATION FILE lfmd-20250506_pre.xml EX-101.PRE 25324
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5859
Mailing Address 236 FIFTH AVENUE SUITE 400 NEW YORK NY 10001
Business Address 236 FIFTH AVENUE SUITE 400 NEW YORK NY 10001 (866) 351-5907
LifeMD, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39785 | Film No.: 25917346
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)